Purgation Therapy in Neurological Disorders: Bridging Siddha Medicine and Modern Neuroscience
Main Article Content
Abstract
Neurological disorders such as Parkinson’s disease, multiple sclerosis, and functional neurological syndromes represent a growing global health burden. Increasing evidence indicates that chronic constipation is not merely a secondary symptom but an early and contributory factor associated with gut–brain axis dysregulation, systemic inflammation, and neuroimmune alterations. The Siddha system of medicine, a traditional medical system practised in India, has long emphasized purgation therapy (Virechanam) as a regulatory intervention for neurological dysfunctions attributed to imbalances in Vatham, the functional principle governing movement and neural activity. This narrative review examines the therapeutic relevance of Siddha-based purgation therapy in the context of contemporary neurogastroenterological and neuroscientific research. By synthesizing evidence from studies on gut dysbiosis, vagal signalling, immune modulation, and neuroinflammation, the review explores conceptual convergences between traditional Siddha principles and modern understandings of the gut–brain axis. Chronic constipation, recognized both as a traditional marker of systemic imbalance and a prodromal feature of neurodegenerative disease, serves as a central point of intersection. Rather than asserting clinical equivalence or therapeutic substitution, this review highlights biological plausibility, shared mechanistic pathways, and translational opportunities through which gut-centred interventions, including purgation-based strategies, may complement contemporary neurological care. The findings support the need for further standardized clinical and mechanistic studies to evaluate the role of traditional detoxification practices within integrative approaches to neurological disorders.
Article Details
Copyright (c) 2026 Thamizhoviya G, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Thakur KT, Albanese E, Giannakopoulos P. Neurological disorders. In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, neurological, and substance use disorders: disease control priorities. 3rd ed. Vol. 4. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 5. Available from: https://www.ncbi.nlm.nih.gov/books/NBK361945/
Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255-265. Available from: https://doi.org/10.1016/s1474-4422(19)30411-9
Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, Paudel KR, et al. Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev. 2024;102357. Available from: https://doi.org/10.1016/j.arr.2024.102357
Kim JE, Park JJ, Lee MR, Choi JY, Song BR, Park JW, Hwang DY, et al. Constipation in Tg2576 mice model for Alzheimer’s disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response. PLoS One. 2019;14(4):e0215205. Available from: https://doi.org/10.1371/journal.pone.0215205
Lin X, Liu Y, Ma L, Ma X, Shen L, Ma X, Chen X, et al. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice. J Transl Med. 2021;19:1-16. Available from: https://doi.org/10.1186/s12967-021-02995-z
Shukla SS, Saraf S. Fundamental aspect and basic concept of siddha medicines. Syst Rev Pharm. 2011;2(1). Available from: https://www.sysrevpharm.org/articles/fundamental-aspect-and-basic-concept-of-siddha-medicines.pdf
Mahendiran M, Gowri V. Parallel analysis of Oruthalai Vaatham in Siddha literature with migrainous neuralgia. Available from: https://velumailusiddha.dharmagroups.in/parallel-analysis-of-oruthalai-vaatham-siddha-literature-with-migrainous-neuralgia/
Rajeshwari M. Understanding the concept of purgation in Siddha medicine: a review. Int J Ayurveda Pharma Res. 2022;10(6). Available from: https://doi.org/10.47070/ijapr.v10i6.2324
Thanigainathan A, Selvalenin C, Lakshmi Kantham T, Vetha Merlin Kumari H, Nalini Sofia H, Mary Sharmila C, Anbarasan B, Meenakumari R. Viresanam – purgation therapy in Siddha. J Siddha. 2021;5(1):52-60. Available from: https://jos.nischennai.org/index.php/jos/article/view/34
Barik S, Prasad BS. Prescribing patterns of Virechana karma in terms of Shuddhi Lakshana. Indian J Health Sci Biomed Res KLEU. 2019;12(2):139-153. Available from: https://kleijhsbr.researchcommons.org/journal/vol12/iss2/9/
Muthiah K, Ganesan K, Ponnaiah M, Parameswaran S. Concepts of body constitution in traditional Siddha texts: a literature review. J Ayurveda Integr Med. 2019;10(2):131-134. Available from: https://doi.org/10.1016/j.jaim.2019.04.002
Chithra L, Christian GJ, Elansekaran S, Ramamoorthy M. An observational study to validate the symptomatology and to evolve the diagnostic methodology of Sirakkamba Vatham through Siddha diagnostic tools. Int J Ayurveda Pharma Res. 2020;8(2):31-37. Available from: https://ijapr.in/index.php/ijapr/article/view/1391/1086
Council of Scientific and Industrial Research Traditional Knowledge Digital Library. Principles of Siddha [seasonal guidelines table]. Traditional Knowledge Digital Library. [cited 2025 Jun 30]. Available from: https://tkdl.res.in/tkdl/langdefault/Siddha/Sid_Principles.asp?GL=Eng
Esakkimuthu S, Mutheeswaran S, Elankani P, Pandikumar P, Ignacimuthu S. Quantitative analysis of medicinal plants used to treat musculoskeletal ailments by non-institutionally trained Siddha practitioners of Virudhunagar district, Tamil Nadu, India. J Ayurveda Integr Med. 2021;12(1):58-64. Available from: https://doi.org/10.1016/j.jaim.2018.11.005
Uma E, Mala T, Geetha AV, Priyanka D. A comprehensive survey of drug-target interaction analysis in allopathy and Siddha medicine. Artif Intell Med. 2024;102986. Available from: https://doi.org/10.1016/j.artmed.2024.102986
Babu CS, Mahadevan M, Rao BS, Ranju V, Bipul R, Bhat A, Essa MM, et al. Management of Huntington's disease: perspectives from the Siddha system of medicine. In: Food for Huntington's disease. New York: Nova Science Publishers, Inc.; 2018;159-180. Available from: https://www.researchgate.net/publication/329865712_Management_of_Huntington's_disease_Perspectives_from_the_Siddha_system_of_medicine
Gangadharan T, Arumugam M. Siddha medicine and modern neuroscience: a synergistic approach to neurological care. 3 Biotech. 2025;15(4):1-13. Available from: https://doi.org/10.1007/s13205-025-04265-x
Sharma T, Meghwal CR, Prajapat M, Sharma AK. Conceptual study of Vata dosha with special reference to nervous system. J Ayurveda Integr Med Sci. 2024;9(2):134-140. Available from: https://jaims.in/jaims/article/view/3123
Sowmya S, Sudha Revathy S, Meenakumari R. Therapeutic potential of Siddha herbomineral formulation “Kukkilathy Chorine” in Parkinsonism: a review. Int J Pharm Sci Rev Res. 2024;84(9):228-341. Available from: https://globalresearchonline.net/ijpsrr/v84-9/37.pdf
Nisha J, Anbu N, Purushothaman I. A review on traditional herbs used in Parkinson’s disease (Nadukku Vatham). World J Pharm Res. 2017;7(16):631-637. Available from: https://doi.org/10.20959/wjpr20178-9217
Mohanraj T. Vaadha noi thoguthi (Vaatha noi nidhanam–800). 1st ed. Chennai: ATSVS Siddha Medical College and Hospital; 2008;28.
Uttarayan KA. Siddha maruthuvanga churukkam. 2nd ed. Chennai: Department of Indian Medicine and Homoeopathy. 2006;138-140, 654.
Indian Medical Practitioners’ Co-operative Pharmacy and Stores Ltd. Formulary of Indian Medical Practitioners’ Co-operative Pharmacy and Stores Ltd. Chennai: IMPCOPS; 2018.
Shanmughavelu HPIM. Noi naadal noi mudhal naadal thirattu. Part 1. Chennai: Department of Indian Medicine and Homoeopathy; 2007.
Thayalini T, Prasad VM. Vatha suram (fever) in literatures of Siddha medicine. J. res. tradit. med. 2018;4(1):21-25. Available from: https://www.tmjournal.org/?mno=298118
Guan Y, Tang G, Li L, Shu J, Zhao Y, Huang L, Tang J, et al. Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management. Arch Pharm Res. 2024;47(2):146-164. Available from: https://doi.org/10.1007/s12272-023-01484-9
Sharma R, Kabra A, Rao MM, Prajapati PK. Herbal and holistic solutions for neurodegenerative and depressive disorders: leads from Ayurveda. Curr Pharm Des. 2018;24(22):2597-2608. Available from: https://doi.org/10.2174/1381612824666180821165741
Suguna M, Arthi G, Mohanaprabha G, Dhineshraman G, Manjula V, Kavitha S, Krishnaveni M. An open-label non-randomized clinical trial on Siddha purgation therapy (Bhedhi) for pacifying Vatham disease using diagnostic tool Neikuri. Int J Ayurveda Pharma Res. 2022;10(11):95-102. Available from: https://doi.org/10.47070/ijapr.v10i11.2602
Yu QJ, Yu SY, Zuo LJ, Lian TH, Hu Y, Wang RD, Zhang W, et al. Parkinson disease with constipation: clinical features and relevant factors. Sci Rep. 2018;8(1):567. Available from: https://www.nature.com/articles/s41598-017-16790-8b
Foster JA, Rinaman L, Cryan JF. Stress and the gut-brain axis: regulation by the microbiome. Neurobiol Stress. 2017;7:124-136. Available from: https://doi.org/10.1016/j.ynstr.2017.03.001
Xu J, Lu Y. The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies. Front Microbiol. 2025;16:1583562. Available from: https://doi.org/10.3389/fmicb.2025.1583562
Chaudhry TS, Senapati SG, Gadam S, Mannam HPSS, Voruganti HV, Abbasi Z, Arunachalam SP, et al. The impact of microbiota on the gut–brain axis: examining the complex interplay and implications. J Clin Med. 2023;12(16):5231. Available from: https://doi.org/10.3390/jcm12165231
Sampson TR, Tansey MG, West AB, Liddle RA. Lewy body diseases and the gut. Mol Neurodegener. 2025;20(1):14. Available from: https://doi.org/10.1186/s13024-025-00804-5
Nakase T, Tatewaki Y, Thyreau B, Mutoh T, Tomita N, Yamamoto S, Taki Y, et al. Impact of constipation on progression of Alzheimer's disease: a retrospective study. CNS Neurosci Ther. 2022;28(12):1964-1973. Available from: https://doi.org/10.1111/cns.13940
O’Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF. The gut microbiota-immune-brain axis: therapeutic implications. Cell Rep Med. 2025;6(3). Available from: https://doi.org/10.1016/j.xcrm.2025.101982
Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota’s effect on mental health: the gut-brain axis. Clin Pract (Lond). 2017;7(4):987. Available from: https://doi.org/10.4081/cp.2017.987
Solanki R, Karande A, Ranganathan P. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration. Front Neurol. 2023;14:1149618. Available from: https://doi.org/10.3389/fneur.2023.1149618
Su H, Mo J, Ni J, Ke H, Bao T, Xie J, Chen W, et al. Andrographolide exerts antihyperglycemic effect through strengthening intestinal barrier function and increasing microbial composition of Akkermansia muciniphila. Oxid Med Cell Longev. 2020;2020:6538930. Available from: https://doi.org/10.1155/2020/6538930
Miri S, Yeo J, Abubaker S, Hammami R. Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome? Front Microbiol. 2023;14:1098412. Available from: https://doi.org/10.3389/fmicb.2023.1098412
Grebenciucova E, VanHaerents S. Interleukin 6: at the interface of human health and disease. Front Immunol. 2023;14:1255533. Available from: https://doi.org/10.3389/fimmu.2023.1255533
Kummer KK, Zeidler M, Kalpachidou T, Kress M. Role of IL-6 in the regulation of neuronal development, survival and function. Cytokine. 2021;144:155582. Available from: https://doi.org/10.1016/j.cyto.2021.155582
Chen W, Wang J, Yang H, Sun Y, Chen B, Liu Y, Zhan J, et al. Interleukin 22 and its association with neurodegenerative disease activity. Front Pharmacol. 2022;13:958022. Available from: https://doi.org/10.3389/fphar.2022.958022
Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203. Available from: https://pubmed.ncbi.nlm.nih.gov/25830558/
Appleton J. The gut-brain axis: influence of microbiota on mood and mental health. Integr Med (Encinitas). 2018;17(4):28. Available from: https://pubmed.ncbi.nlm.nih.gov/31043907/
Ferreira ACFM, Eveloff RJ, Freire M, Santos MTBR. The impact of oral-gut inflammation in cerebral palsy. Front Immunol. 2021;12:619262. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.619262/full
Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, Khaw KY, et al. Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024;9(1):37. Available from: https://doi.org/10.1038/s41392-024-01743-1
Pedrosa Carrasco AJ, Timmermann L, Pedrosa DJ. Management of constipation in patients with Parkinson’s disease. NPJ Parkinsons Dis. 2018;4(1):6. Available from: https://doi.org/10.1038/s41531-018-0042-8
Becker A, Faßbender K, Oertel WH, Unger MM. A punch in the gut–intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord. 2019;60:43-45. Available from: https://doi.org/10.1016/j.parkreldis.2018.09.032
Chuyue DY, Xu QJ, Chang RB. Vagal sensory neurons and gut-brain signaling. Curr Opin Neurobiol. 2020;62:133-140. Available from: https://doi.org/10.1016/j.conb.2020.03.006
Forsythe P, Bienenstock J, Kunze WA. Vagal pathways for microbiome-brain-gut axis communication. In: Microbial endocrinology: the microbiota-gut-brain axis in health and disease. 2014. p. 115-133. Available from: https://doi.org/10.1007/978-1-4939-0897-4_5
Farzi A, Fröhlich EE, Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15(1):5-22. Available from: https://doi.org/10.1007/s13311-017-0600-5
Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne). 2020;11:508738. Available from: https://doi.org/10.3389/fendo.2020.00025
Fock E, Parnova R. Mechanisms of blood–brain barrier protection by microbiota-derived short-chain fatty acids. Cells. 2023;12(4):657. Available from: https://doi.org/10.3390/cells12040657
Yang H, Kim D, Yang Y, Bagyinszky E, An SSA. TREM2 in neurodegenerative disorders: mutation spectrum, pathophysiology, and therapeutic targeting. Int J Mol Sci. 2025;26(15):7057. Available from: https://doi.org/10.3390/ijms26157057
Biswas A, Petnicki-Ocwieja T, Kobayashi KS. Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J Mol Med (Berl). 2012;90(1):15-24. Available from: https://doi.org/10.1007/s00109-011-0802-y
Ramakrishna BS, Patankar R. Antibiotic-associated gut dysbiosis. J Assoc Physicians India. 2023;71(11):62-68. Available from: https://doi.org/10.59556/japi.71.0381
Yang Z, Wei C, Li X, Yuan J, Gao X, Li B, Tang J, et al. Association between regular laxative use and incident dementia in UK Biobank participants. Neurology. 2023;100(16):e1702-e1711. Available from: https://doi.org/10.1212/wnl.0000000000207081
Camacho M, Macleod AD, Maple-Grødem J, Evans JR, Breen DP, Cummins G, Williams-Gray CH, et al. Early constipation predicts faster dementia onset in Parkinson’s disease. NPJ Parkinsons Dis. 2021;7(1):45. Available from: https://doi.org/10.1038/s41531-021-00191-w
Yao L, Liang W, Chen J, Wang Q, Huang X. Constipation in Parkinson’s disease: a systematic review and meta-analysis. Eur Neurol. 2023;86(1):34-44. Available from: https://doi.org/10.1159/000527513
Warnecke T, Schäfer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 2022;8(1):31. Available from: https://doi.org/10.1038/s41531-022-00295-x
Kang J, Lee M, Park M, Lee J, Lee S, Park J, Kim T, et al. Slow gut transit increases the risk of Alzheimer’s disease: an integrated study of the bi-national cohort in South Korea and Japan and Alzheimer’s disease model mice. J Adv Res. 2024;65:283-295. Available from: https://doi.org/10.1016/j.jare.2023.12.010
Rota L, Pellegrini C, Benvenuti L, Antonioli L, Fornai M, Blandizzi C, Colla E, et al. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy. Transl Neurodegener. 2019;8(1):5. Available from: https://doi.org/10.1186/s40035-019-0146-z
Kang SH, Lee J, Koh SB. Constipation is associated with mild cognitive impairment in patients with de novo Parkinson’s disease. J Mov Disord. 2021;15(1):38. Available from: https://doi.org/10.14802/jmd.21074
Miyamoto T, Nakajima I, Arikawa T, Miyamoto M. Bowel movement frequency and difficult defecation using constipation assessment scale in patients with isolated REM sleep behavior disorder. Clin Parkinsonism Relat Disord. 2024;11:100269. Available from: https://doi.org/10.1016/j.prdoa.2024.100269
Leta V, Urso D, Batzu L, Weintraub D, Titova N, Aarsland D, Chaudhuri KR, et al. Constipation is associated with development of cognitive impairment in de novo Parkinson’s disease: a longitudinal analysis of two international cohorts. J Parkinsons Dis. 2021;11(3):1209-1219. Available from: https://doi.org/10.3233/jpd-212570
Su M, Wang S, Cheng O, Xie K, Peng J, Du X, Feng T, et al. Constipation is associated with emotional and cognitive impairment in patients with Parkinson’s disease: a clinical and brain functional study. Neuroscience. 2024;559:17-25. Available from: https://doi.org/10.1016/j.neuroscience.2024.08.027
Wang Q, Yi T, Jiang X. Constipation and risk of cognitive impairment and dementia in adults: a systematic review and meta-analysis. Front Neurol. 2025;16:1600952. Available from: https://doi.org/10.3389/fneur.2025.1600952
Soni S, Sasmal G, Bhardwaj V. Physiological concept of Vata Dosha in relation to brain function. J Ayurveda Integr Med Sci. 2024;9(5):169-171. Available from: https://jaims.in/jaims/article/view/3396
Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ. Constipation preceding Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87(7):710-716. Available from: https://doi.org/10.1136/jnnp-2015-311680
Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2003;2(2):107-116. Available from: https://doi.org/10.1016/s1474-4422(03)00307-7
Gao H, He C, Hua R, Liang C, Wang B, Du Y, et al. Underlying beneficial effects of rhubarb on constipation-induced inflammation, disorder of gut microbiome and metabolism. Front Pharmacol. 2022;13:1048134. Available from: https://doi.org/10.3389/fphar.2022.1048134
Jalanka J, Salonen A, Salojärvi J, Ritari J, Immonen O, Marciani L, et al. Effects of bowel cleansing on the intestinal microbiota. Gut. 2015;64(10):1562-1568. Available from: https://doi.org/10.1136/gutjnl-2014-307240
Derrien M, van Hylckama Vlieg JE. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015;23(6):354-366. Available from: https://doi.org/10.1016/j.tim.2015.03.002
O'Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, Fülling C, et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546:111572. Available from: https://doi.org/10.1016/j.mce.2022.111572
Rajilic-Stojanovic M, Jonkers DM, Salonen A, Hanevik K, Raes J, Jalanka J, et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol. 2015;110(2):278-287. Available from: https://doi.org/10.1038/ajg.2014.427
Nagata N, Takeuchi T, Masuoka H, Aoki R, Ishikane M, Iwamoto N, et al. Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications. Gastroenterology. 2023;164(2):272-288. Available from: https://doi.org/10.1053/j.gastro.2022.09.024
Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(4):1125-1136. Available from: https://doi.org/10.1016/j.cell.2016.10.020
Di Vincenzo F, Del Gaudio A, Pettit V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024;19(2):275-293. Available from: https://doi.org/10.1007/s11739-023-03374-w
Zhang Y, Zhu X, Yu X, Novák P, Gui Q, Yin K. Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy. Front Nutr. 2023;10:1120168. Available from: https://doi.org/10.3389/fnut.2023.1120168
Foster JA, Neufeld KAM. Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-312. Available from: https://doi.org/10.1016/j.tins.2013.01.005
Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462-467. Available from: https://doi.org/10.1038/s41586-019-1291-3
Feng J, Zheng N, Fan X, Li S, Jiang Y, Yi X, et al. Association of laxatives use with incident dementia and modifying effect of genetic susceptibility: a population-based cohort study with propensity score matching. BMC Geriatr. 2023;23(1):122. Available from: https://doi.org/10.1186/s12877-023-03854-w
Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2016;(8). Available from: https://doi.org/10.1002/14651858.cd009118.pub3
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine and neuroinflammation. Nat Med. 2023;29(2):220-230. Available from: https://doi.org/10.1038/nm.3145
Subbarayappa BV. Siddha medicine: an overview. Lancet. 1997;350(9094):1841-1844. Available from: https://doi.org/10.1016/s0140-6736(97)04223-2